WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its eXpDNA™ plasmid platform, established from the Company’s contract ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback